influenza viruses Flashcards
Antiviral agents used to treat influenza viruses :
Amantadine
Oseltamivir + Zanamivir (Neuraminidase inhibitors)
Therapeutic uses of Amantadine:
1) to prevent and treat influenza type A (not B)
(Given with 480h >decrease viral symptoms 2days)
2) to treat Parkinson’s disease (reduce tremor & dyskinesia in 70%, its effectiveness fades)
M.o.a of amantadine:
1) Block influenza A M1 ion channel protein
2) reduce influx of protons
3) inhibit viral capsule disassembly (inhibit uncoating)
Pharmacokinetic of Amantadine:
orally available
well absorbed from the GI tract
Eliminated by kidney (dose must be reduced in renal insufficiency)
Adverse effects of Amantadine:
Tremor Nervousness Confusion Dizziness Peripheral edema (ankle edema) Livdo reticularis * unique
Therapeutic uses of Neuraminidase Inhibitors (Oseltamivir & Zanamivir):
1) prevention and treatment of influenza A & B
Within 2 days
Pharmacokinetic of Oseltamivir:
Well absorbed from GIT (bioavailability > 0.8)
prodrug & hydrolyzed by the liver enzymes to its active metabolite
Pharmacokinetics of Zanamivir:
1) Extremely poor absorption form GIT
2) Available as a dry powder for oral inhalation
Side effects of Neuraminidase Inhibitors:
❖ Well-tolerated (nausea/vomiting and headache)
❖ Bronchospasm
❖ They have less CNS adverse effects compared to amantadine
M.o.a of Neuraminidase Inhibitors (oseltamivir + zanamivir):
Competitive inhibitor of neuraminidase enzyme > prevent the cleavage of sialic acid residues on the surface of the infected host cell and thus prevents the release of the progeny visions from infected cells.